Kohan, Donald E.

Endothelin

Davenport, A. P., Hyndman, K. A., Dhaun, N., Southan, C., Kohan, D. E., Pollock, J. S., Pollock, D. M., Webb, D. J., & Maguire, J. J. (2016) · Pharmacological Reviews

Nitric Oxide and Endothelin EffectsRenin-Angiotensin System Studies

Cited by 772

Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control

Kohan, D. E., Fioretto, P., Tang, W., & List, J. F. (2014) · Kidney International

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 652

Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption

Guan, Y., Hao, C., Cha, D. R., Rao, R., Lu, W., Kohan, D. E., Magnuson, M. A., Redha, R., Zhang, Y., & Breyer, M. D. (2005) · Nature Medicine

Peroxisome Proliferator-Activated ReceptorsIon Transport and Channel Regulation

Cited by 608

Atrasentan in Patients with IgA Nephropathy

Heerspink, H. J. L., Jardine, M., Kohan, D. E., Lafayette, R. A., Levin, A., Liew, A., Zhang, H., Lodha, A., Gray, T., Wang, Y., et al. (2025) · New England Journal of Medicine

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 142

Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Heerspink, H. J. L., Jardine, M. J., Kohan, D. E., Lafayette, R., Levin, A., Liew, A., Zhang, H., Noronha, I. L., Mastroianni-Kirsztajn, G., Chow, S., et al. (2026) · The Lancet

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 12

Adenylyl cyclase 4 does not regulate collecting duct water and sodium handling

Kittikulsuth, W., Stuart, D., & Kohan, D. E. (2014) · Physiological Reports

Ion Transport and Channel RegulationRenin-Angiotensin System Studies

Cited by 8